WhiteHDRiversJTMaslowskiAHEffect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med1989; 320: 817–21.
2.
SheehanFHBraunwaldECannerPThe effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation1987; 75: 817–29.
3.
Gruppo Italiano per lo studio della Sopravvivenza nell'Infarto Miocardico GISSI-2.A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet1990; 336: 65–71.
4.
TPA, Eminase, streptokinase mortality rates are similar, according to study of 46,000 patients. Blue Sheet1991; 34 (10):3–4.
5.
International Study Group.In-hospitality mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet1990; 336: 71–5.
6.
ChesebroJHKnatterudGRobertsRThrombolysis in Myocardial Infarction (TIMI) Trial Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation1987; 7: 142–54.
7.
The TIMI Study Group.The Thrombolysis in Myocardial Infarction (TIMI) Trial Phase I findings. N Engl J Med1985; 312: 932–6.
8.
RelmanAS. Intravenous thrombolysis in acute myocardial infarction: A progress report (editorial). N Engl J Med1985; 312: 915–6.
9.
JohnsJAGoldHKLeinbachRCPrevention of coronary artery reocclusion and reduction in the late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. Circulation1988; 78: 546–56.
10.
HoggKJGemmillJDBurnsJMAngiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet1990; 335: 254–8.
11.
PacouretG, Charbonier B, for the Irs Ii Study.. Multicenter European randomized trial of anistreplase versus streptokinase in acute myocardial infarction (abstract). Circulation1989; 80 (suppl II):II–40.
12.
AndersonJLSorensenSGMorenoFQuantitative assessment of coronary stenosis after thrombolysis in acute myocardial infarction: Results of a randomized study of anistreplase and streptokinase (abstract). J Am Coll Cardiol1990; 15 (suppl A):218A.
13.
AndersonJLMarshallHWBrayBEA randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med1983; 308: 1312–8.
14.
SwanHJ. Thrombolysis in acute evolving myocardial infarction. A new potential for myocardial salvage (editorial). N Engl J Med1983; 308: 1354–5.
15.
KhajaFWaltonJAJrBrymerJFIntracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective trial. N Engl J Med1983; 308: 1305–11.
16.
MatheyDGSchoferJSheehanFHBecherHTilsnerVDodgeHT. Intravenous urokinase in acute myocardial infarction. Am J Cardiol1985; 55: 878–82.
17.
KorenGWeissATHasinYPrevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med1985; 313: 1384–9.
18.
AndersonJLMarshallHWAskinsJCA randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation1984; 70: 606–18.
19.
SchroederRBiaminoGEnz-RudigerLIntravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation1983; 67: 536–48.
20.
SherrySMarderV. Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction. Ann Intern Med1991; 114: 417–23.
21.
SherryS. Tissue plasminogen activator (t-PA): Will it fulfill its promise?N Engl J Med1985; 314: 1014–7.
22.
SherryS. Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving myocardial infarction?Am J Med1987; 59: 984–9.
23.
GanzW. The thrombolysis in myocardial infarction (TIMI) trial (letter). N Engl J Med1985; 313: 1018.
24.
SherryS. Appraisal of various thrombolytic agents in the treatment of acute myocardial infarction. Am J Med1987; 83 (suppl 2A):31–46.
25.
MarderVJSherryS. Thrombolytic therapy: Current status. N Engl J Med1988; 318: 1512–20, 1585–95.
